(2026). GFPT2 upregulation predicts poor prognosis and is associated with TGF-β/Smad activation in lung adenocarcinoma. Discover Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"GFPT2 Upregulation Predicts Poor Prognosis and Is Associated with TGF-β/Smad Activation in Lung Adenocarcinoma."
Discover Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"GFPT2 Upregulation Predicts Poor Prognosis and Is Associated with TGF-β/Smad Activation in Lung Adenocarcinoma."
Discover Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.